News | December 20, 2022
Ipca acquires further 6.53% of equity share of Trophic Wellness
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
The joint venture will help both the parties to further develop the high-margin service business
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
Subscribe To Our Newsletter & Stay Updated
